Database

Startups

Main Industry
Biotechnology
Main Product/Service
Our Universal Antibody Lock™ is an innovative proprietary platform designed to generate conditionally-activated antibody therapeutics for various antibody formats, including monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies. This technology enhances antibody selectivity while reducing on-target toxicity, providing safer and more effective treatment solutions for patients.
Founded Year
2021
Unified Business No.
90663465
Status
Active
Number of Employees
0
Total Paid-in Capital
69,100,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
PrecisemAb Biotech develops safer antibody therapeutics using its patented Antibody Lock™ platform, enabling tumor microenvironment–specific activation to reduce systemic toxicity. Protected in 18 countries and licensed to GlycoNex in 2024, the platform is expanding into bispecifics and ADCs, with proprietary asset PSM101 targeting IND submission in 2027.



More ↓

Similar Companies

TAHO PHARMACEUTICALS LTD.

1. TAH4411 Ondansetron ODF
2. TAH3311 Apixaban Oral Film
3. TAH3341 Apixaban Oral Extend Release Film
4. TAH2211 Buprenorphine/Naloxone Sublingual Film
5. TAH2231 Naloxone Buccal Film
6. TAH9922 Atomoxetine Oral Liquid
7. TAH9901 Methylphenidate Patch

Taiwan Universe BioMedicine Inc.

Main Product
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up